BDBM72348 (1R,3R)-1,3-diallyl-5,8-dibromo-1,2,3,4-tetrahydroisoquinoline;hydrochloride::(1R,3R)-5,8-bis(bromanyl)-1,3-bis(prop-2-enyl)-1,2,3,4-tetrahydroisoquinoline;hydrochloride::(1R,3R)-5,8-dibromo-1,3-bis(prop-2-enyl)-1,2,3,4-tetrahydroisoquinoline;hydrochloride::MLS000701400::SMR000228770::cid_15945546

SMILES [2H]C1([2H])N2C(=O)c3cc(F)c(F)cc3N1c1ccc(F)c(Cl)c1CNCCc1[nH]c(=O)ccc12

InChI Key InChIKey=PWYXIEYQBHGUIV-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72348   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72348BDBM72348(9-Chloro-2,3,8-trifluoro-10,11,12,13-tetrahydro-19...)
Affinity DataIC50: 5.01nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent